Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aikaterini Sfiridaki

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|December 13, 2003
Elevated serum angiogenin in multiple myelomaMichael G Alexandrakis, Freda H Passam, Aikaterini Sfiridaki, et al.
Journal of Hematology & Oncology|May 10, 2011
Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myelomaAikaterini Sfiridaki, Spiros Miyakis, Constantina Pappa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 20, 2007
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myelomaMichael G Alexandrakis, Aikaterini Sfiridaki, Spiros Miyakis, et al.
European Journal of Internal Medicine|September 12, 2006
Serum interleukin-17 and its relationship to angiogenic factors in multiple myelomaMichael G Alexandrakis, Constantina A Pappa, Spiros Miyakis, et al.
Pathology Oncology Research : POR|March 5, 2013
The significance of non correlation between interleukin-8 serum levels with bone marrow microvascular density in patients with myeloma multipleConstantina A Pappa, George Tsirakis, Anna Boula, et al.
Acta Haematologica|December 3, 2020
Role of Inherited Thrombophilia Risk Factors in Patients with CKD-5 Receiving HaemodialysisDimitra Liapi, Aikaterini Sfiridaki, Aikaterini Livadiotaki, et al.
Clinical Chemistry and Laboratory Medicine|September 24, 2005
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone diseaseAikaterini Sfiridaki, Spiros Miyakis, George Tsirakis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Hematology Journal : the Official Journal of the European Haematology Association|December 13, 2003
Elevated serum angiogenin in multiple myelomaMichael G Alexandrakis, Freda H Passam, Aikaterini Sfiridaki, et al.
Journal of Hematology & Oncology|May 10, 2011
Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myelomaAikaterini Sfiridaki, Spiros Miyakis, Constantina Pappa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 20, 2007
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myelomaMichael G Alexandrakis, Aikaterini Sfiridaki, Spiros Miyakis, et al.
European Journal of Internal Medicine|September 12, 2006
Serum interleukin-17 and its relationship to angiogenic factors in multiple myelomaMichael G Alexandrakis, Constantina A Pappa, Spiros Miyakis, et al.
Pathology Oncology Research : POR|March 5, 2013
The significance of non correlation between interleukin-8 serum levels with bone marrow microvascular density in patients with myeloma multipleConstantina A Pappa, George Tsirakis, Anna Boula, et al.
Acta Haematologica|December 3, 2020
Role of Inherited Thrombophilia Risk Factors in Patients with CKD-5 Receiving HaemodialysisDimitra Liapi, Aikaterini Sfiridaki, Aikaterini Livadiotaki, et al.
Clinical Chemistry and Laboratory Medicine|September 24, 2005
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone diseaseAikaterini Sfiridaki, Spiros Miyakis, George Tsirakis, et al.
Pageof 1